Launching out of the Y Combinator accelerator, Verge Genomics is looking to find cures for brain diseases. Diseases such as Alzheimers, ALS, and Parkinsons are complex diseases that usually involve a network of genes, as opposed to a single gene. According to the company, over 99.9 percent of drug discoveries ultimately fail because researchers are looking at a single gene at a time. But… Read More...